Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.
about
A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidityPharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practiceInterventions to improve health outcomes for patients with low literacy. A systematic review.Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC)Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management.A review of pharmacist contributions to diabetes care in the United States.Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review.The impact of clinical pharmacy services integrated into medical homes on diabetes-related clinical outcomes.Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled studyThe pharmaceutical care of patients with type 2 diabetes mellitus.Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.The relationship between literacy and glycemic control in a diabetes disease-management program.Management of prediabetes: a comparison of the treatment approaches utilized by a family practice clinic and an internal medicine/endocrinology practice.Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health center.Initial Experience of Clinical Pharmacy Services Delivered by Computer Communication via Cisco Jabber Video in a US Veterans Administration Medical Center.Cost-Effectiveness of Reducing Glycaemic Episodes Through Community Pharmacy Management of Patients with Type 2 Diabetes Mellitus
P2860
Q24795358-65581E3F-1DC6-488B-8516-7289A0CEDF6BQ28192612-D74D792E-BE24-4C0F-8E4F-324C3ED48810Q34722762-B72C3CC5-AE7D-4897-B17B-32C8F27C717FQ36171359-A4AACA81-AAD5-42DA-81C2-29D23EADA7B4Q36915765-AE7C0159-61D4-4BB3-A059-B8A3E4C99ED0Q37867283-C665D005-BE6C-4056-A0BF-C4A70C6DF0C4Q38188471-0313C25E-29F7-4273-B76A-FD3B9FEF194BQ39960847-7BDF867D-9BE8-436F-AA7D-ED1DDB5BCF76Q42133031-A514EA11-1814-405C-869C-C191171A6163Q42928217-876B8C53-D008-4DE6-BB3E-E8D0CA22F8E5Q44805674-17874BEA-D9F8-4211-B08C-789A86E21682Q44850429-30FBE750-D633-4AF4-A74D-988838066051Q45270379-FA63EDC2-6D45-4F0D-8A68-73680AB0E4C2Q46378373-3CCA8AF4-9E4C-4E7C-8CE1-F6C61D64F0D7Q55225590-0F67BCD9-2DB2-41A4-8E52-CD478CCE1690Q57200162-E137AB57-74E6-42F2-9708-A2DF612A797A
P2860
Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pharmacist-led, primary care-b ...... h-risk patients with diabetes.
@en
Pharmacist-led, primary care-b ...... h-risk patients with diabetes.
@nl
type
label
Pharmacist-led, primary care-b ...... h-risk patients with diabetes.
@en
Pharmacist-led, primary care-b ...... h-risk patients with diabetes.
@nl
prefLabel
Pharmacist-led, primary care-b ...... h-risk patients with diabetes.
@en
Pharmacist-led, primary care-b ...... h-risk patients with diabetes.
@nl
P2093
P2860
P1476
Pharmacist-led, primary care-b ...... h-risk patients with diabetes.
@en
P2093
Betsy Bryant
Cheryl Horlen
Robb Malone
Russell Rothman
P2860
P356
10.1177/106286060301800202
P577
2003-03-01T00:00:00Z